Session
Speaker
Presentation
M1
Stephan Ogenstad
Simulation for Designing and Analyzing Clinical Trials
M-2
Dejun Tang
Comparison of Statistical Analysis Methods using Modeling and Simulation in Modern Protocol Design
M-3
Naitee Ting
Dose Finding in Drug Development: Study Design Considerations
M-4
Mark J. van der Laan
Resampling Based Multiple Testing: Controlling Proportion of False Positives
M-5
Michael O'Connell
Standardized Graphics for Safety using S-Plus Software
M-6
Ralph Raymond & Frank Shen
Model Based Adaptive Design
M-7
Tim Montague
Bioequivalence Trials Designed Using Adaptive Methodologies
Keynote Address
Greg Campbell
The World of Medical Devices and its Increasing Impact on Pharmaceutical Statistics
T-1
Rong Liu
A Comparison of Methods for Longitudinal Data Missing Due to Truncation
T-2
Julia Wang & Akiko Okamoto
Rescue Behavior and Imputation Strategies in Analgesic Studies
T-3
Robert E. Johnson
Multivariate Assays with Values Below the Lower Limit of Quantitation: Parametric Estimation by Imputation and Maximum Likelihood
T-4
Andrew Strahs
Variability in Gene Expression in Healthy Volunteers
T-5
Shein-Chung Chow & Mark Chang
Adaptive Design Methods in Clinical Trials-Part 1
Adaptive Design Methods in Clinical Trials-Part II
W-FDA
Mohammad Huque
On Some Statistical Considerations in Planning and Testing of Multiple Endpoint Hypotheses in Clinical Trials
W-FDA
Guoxing (Greg) Soon
Issues and Considerations for Composite Endpoints Use in Clinical Trials
W-FDA
Atiar Rahman
Recent Results concerning Multiplicities in Animal Carcinogenicity Studies
W-FDA
Alex Dmitrienko
Tree-structured Gatekeeping Procedures in Clinical Trials with Multiple Objectives